Verition Fund Management LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1454027
GREENWICH, CT
Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,853,085
+$4,423,221 QoQ
Shares Held
777,738
+1195.4% QoQ
Ownership
0.300%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 177 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names. MRVI ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
This page
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in MRVI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,853,085 | 777,738 | Shares | Sole | 2026-08-14 | |
| 2024-06-30 | $429,864 | 60,037 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $1,913,548 | 153,946 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $196,013 | 13,991 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $327,455 | 22,883 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $916,052 | 32,244 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $924,920 | 26,224 | Shares | Sole | 2022-06-02 | |
| 2021-06-30 | $244,120 | 5,850 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||